Jue Pu
Director/Board Member at LEPU BIOPHARMA CO., LTD.
Net worth: 63 M $ as of 30/04/2024
Profile
Jue Pu was the founder of CG Oncology, Inc. founded in 2010, where he held the title of Director from 2010 to 2018.
He is currently a Director at Inspirna, Inc. since 2018 and a Non-Executive Director at Lepu Biopharma Co., Ltd.
since 2020.
Mr. Pu was also a Director at CG Oncology, Inc. from 2019 to 2023.
Mr. Pu received his graduate degree from Stanford University in 2013 and his undergraduate degree from The Wharton School of the University of Pennsylvania in 2012.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 24/05/2024 | 90,000,000 ( 5.61% ) | 63 M $ | 30/04/2024 |
Jue Pu active positions
| Companies | Position | Start |
|---|---|---|
| LEPU BIOPHARMA CO., LTD. | Director/Board Member | 22/04/2020 |
Inspirna, Inc.
 Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | Director/Board Member | 01/10/2018 |
Former positions of Jue Pu
| Companies | Position | End |
|---|---|---|
| CG ONCOLOGY, INC. | Director/Board Member | 01/10/2023 |
| CG ONCOLOGY, INC. | Founder | 01/01/2018 |
Training of Jue Pu
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
| Stanford University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| CG ONCOLOGY, INC. | Health Technology |
| LEPU BIOPHARMA CO., LTD. | Health Technology |
| Private companies | 1 |
|---|---|
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Jue Pu
